Patient-Centered Outcomes of Implantable Defibrillator Therapy in Older Patients
Patient-Centered Outcomes of Implantable Defibrillator Therapy in Older Patients
批准号:
8726279
负责人:
Daniel Bruce Kramer
金额:
$20.49万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2017-06-30
关键词:
AddressAdmission activityAdvance Care PlanningAdvance DirectivesAgeCardiacCardiologyCardiovascular systemCaringCessation of lifeCharacteristicsClinicalDataData SetDatabasesDevicesElderlyEthicsFaceFamilyGoalsGuidelinesHealthHealth ServicesHealthcareHealthcare Power of AttorneyHeart DiseasesHeart failureHome Nursing CareHospice CareHospitalizationHospitalsImplantImplantable DefibrillatorsIncidenceIndividualInstitutionalizationInterventionInterviewIsraelKnowledgeLeft Ventricular Ejection FractionLifeLife Support CareLinkMedical centerMedicareMethodologyNursing HomesOutcomePatient-Focused OutcomesPatientsPatternPersonsPoliciesPopulation StudyPredisposing FactorProspective StudiesProviderProxyRecruitment ActivityRegistriesRenal functionResearchResearch PersonnelRiskRisk FactorsScheduleShockSiteStratificationSudden DeathTelephoneTimeUncertaintyWorkagedbaseclinical decision-makingclinical riskcostdata registrydisabilityend of lifeexperiencefollow-uphospice environmentimplantationimprovedmortalitynovelolder patientpatient orientedtooltrend
中文摘要
描述(由申请人提供):每年有超过50,000个植入型心脏转复除颤器(ICD)被放置在65岁的患者身上。人口趋势和相关的心脏病负担将使数百万老年心脏病患者在未来几年有资格使用这些设备。这些患者在ICD植入后的临床病程和医疗保健需求方面面临着重要的不确定性,必须权衡这一点与没有该设备的猝死风险。对于老年患者来说,两个最具挑战性和最昂贵的医疗过渡包括疗养院(NH)和临终关怀入院。哪些ICD患者最终需要NH或临终关怀,以及何时需要,这是完全未知的。此外,他们更广泛的临终经历还没有得到很好的描述。这项建议使用两种互补的方法来解决与老年ICD患者的临床病程、卫生保健需求和临终经历相关的知识差距。首先,2005年至2010年国家心血管数据登记处-ICD登记处的数据将与最小数据集和医疗保险数据相联系,以检查ICD植入后需要NH和临终关怀的老年ICD患者的利用模式和结果。其次,将从贝丝以色列女执事医疗中心的ICD患者和65名ICD患者收集主要数据,以检查次级数据集中没有的关键生命结局。具体目标是:1:描述发病率并确定(A)长期NH护理和(B)在ICD植入后最多3年的约300,000名ICD接受者中的临终关怀入院;2:描述和比较ICD接受者的结果,包括:a)那些被NHS和未被NHS接纳的人植入后的存活率,以及(B)在生命的最后90天和II.负担的过渡(住院或NH入院)。已入院和未入院的死者(N~90,000)的死亡地点;以及3:对75名非卧床ICD患者进行为期两年的前瞻性试点研究,以确定以下事项:提前护理计划(例如,正式的医疗保健委托书;预先指示;与提供者的讨论);护理的主要目标(例如,延长生命与舒适度);卫生服务使用(例如,住院、临终关怀、NH);和临终结局(现场、ICD电击/停用、干预、临终关怀的使用)和临终关怀质量(工具包死后丧亲访谈)的死者(N~20)。影响:这项研究将产生有关ICD老年患者的临床病程、卫生保健需求和临终经历的新数据。AIMS 1和2将利用国家数据库来检查植入后需要长期NH和临终关怀的老年ICD患者的发病率和结果。目标3将确定对老年ICD患者进行前瞻性研究的可行性,并产生关于他们临终经历的初步数据。这项工作代表了更好地为老年患者使用ICD的临床和政策决策提供信息的关键步骤。
英文摘要
DESCRIPTION (provided by applicant): More than 50,000 implantable cardioverter-defibrillators (ICDs) are placed annually in patients aged > 65. Demographic trends and the associated burden of heart disease will make millions more older cardiac patients eligible for these devices in the coming years. These patients face important uncertainties regarding their clinical course and health care needs after ICD implantation, which must be weighed against the risk of sudden death without the device. Two of the most challenging and costly health care transitions for older patients include nursing home (NH) and hospice admission. Which ICD recipients ultimately require NH or hospice care, and when, is entirely unknown. Additionally, their broader end-of-life experiences have not been well- characterized. This proposal addresses knowledge gaps related to the clinical course, health care needs, and end-of-life experiences of older ICD patients using 2 complementary approaches. First, data in the National Cardiovascular Data Registry - ICD Registry from 2005 to 2010 will be linked to Minimum Data Set and Medicare data to examine the utilization patterns and outcomes of older ICD patients needing NH and hospice care following ICD implantation. Second, primary data will be collected from ICD patients > 65 at the Beth Israel Deaconess Medical Center to examine key end-of-life outcomes unavailable in the secondary dataset. The Specific Aims are: 1: To describe the incidence and identify baseline risk factors for (a) long-term NH care and (b) hospice admission among ~ 300,000 ICD recipients > 65 up to 3 years after ICD implantation; 2: To describe and compare outcomes among ICD recipients, including: a) survival following implantation for those who were and were not admitted to NHs, and (b) i. burdensome transitions (hospitalization or NH admission) in last 90-days of life and ii. site of death for decedents (N~ 90,000) who were and were not admitted to hospice; and 3: To conduct a 2-year pilot prospective study among 75 ambulatory ICD patients > 65 to ascertain the following: advance care planning (e.g. formal power of attorney for health care; advance directives; discussions with providers); main goal of care (e.g. life prolongation vs. comfort); health service use (e.g. hospitalizations, hospice, NH); and end-of-life outcomes (site, ICD shocks/deactivation, interventions, hospice use) and quality of end-of-life care (Toolkit After-death Bereaved Family Interview) among those who die (N~20). IMPACT: This research will yield novel data about the clinical course, health care needs and end- of-life experiences of older patients with ICDs. Aims 1 and 2 will leverage national databases to examine the incidence and outcomes of older ICD patients needing long-term NH and hospice care post-implantation. Aim 3 will establish the feasibility of conducting a prospective study of older ICD patients and yield preliminary data regarding their end-of-life experiences. This work represents key steps towards better informing clinical and policy decisions regarding the use of ICDs among older patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prospective Investigation of Palliative and End-of-Life ExpeRiences with ICDs (PIPER-ICD) Study
-
批准号:10517570
-
项目类别:
-
资助金额:$84.44万
-
财政年份:2022
-
负责人:Daniel Bruce Kramer
-
依托单位:
Prospective Investigation of Palliative and End-of-Life ExpeRiences with ICDs (PIPER-ICD) Study
-
批准号:10666588
-
项目类别:
-
资助金额:$73.42万
-
财政年份:2022
-
负责人:Daniel Bruce Kramer
-
依托单位:
The Trajectories and Clinical Experiences of ICD Therapy (TRACER-ICD) Study
-
批准号:10209545
-
项目类别:
-
资助金额:$76.71万
-
财政年份:2021
-
负责人:Daniel Bruce Kramer
-
依托单位:
The Trajectories and Clinical Experiences of ICD Therapy (TRACER-ICD) Study
-
批准号:10393632
-
项目类别:
-
资助金额:$68.07万
-
财政年份:2021
-
负责人:Daniel Bruce Kramer
-
依托单位:
The Trajectories and Clinical Experiences of ICD Therapy (TRACER-ICD) Study
-
批准号:10608085
-
项目类别:
-
资助金额:$71.49万
-
财政年份:2021
-
负责人:Daniel Bruce Kramer
-
依托单位:
Patient-Centered Outcomes of Implantable Defibrillator Therapy in Older Patients
-
批准号:8593639
-
项目类别:
-
资助金额:$20.02万
-
财政年份:2013
-
负责人:Daniel Bruce Kramer
-
依托单位: